6LJ5
Crystal structure of NDM-1 in complex with D-captopril derivative wss04145
6LJ5 の概要
エントリーDOI | 10.2210/pdb6lj5/pdb |
関連するPDBエントリー | 5ZJ2 6LIP 6LIZ 6LJ0 6LJ1 6LJ2 6LJ4 |
分子名称 | Metallo-beta-lactamase type 2, 1,2-ETHANEDIOL, 1-[(2S)-2-methyl-3-sulfanyl-propanoyl]piperidine-4-carboxylic acid, ... (5 entities in total) |
機能のキーワード | ndm-1, metallo-beta-lactamase, antibiotic resistent, inhibitor, thio compounds, antibiotic, hydrolase |
由来する生物種 | Klebsiella pneumoniae |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 26056.02 |
構造登録者 | |
主引用文献 | Ma, G.,Wang, S.,Wu, K.,Zhang, W.,Ahmad, A.,Hao, Q.,Lei, X.,Zhang, H. Structure-guided optimization of D-captopril for discovery of potent NDM-1 inhibitors. Bioorg.Med.Chem., 29:115902-115902, 2020 Cited by PubMed Abstract: β-lactam antibiotics have long been the mainstay for the treatment of bacterial infections. New Delhi metallo-β-lactamase 1 (NDM-1) is able to hydrolyze nearly all β-lactam antibiotics and even clinically used serine-β-lactamase inhibitors. The wide and rapid spreading of NDM-1 gene among pathogenic bacteria has attracted extensive attention, therefore high potency NDM-1 inhibitors are urgently needed. Here we report a series of structure-guided design of D-captopril derivatives that can inhibit the activity of NDM-1 in vitro and at cellular levels. Structural comparison indicates the mechanisms of inhibition enhancement and provides insights for further inhibitor optimization. PubMed: 33302045DOI: 10.1016/j.bmc.2020.115902 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.26 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
